# Critique And Budget Summary

Campaign: `ALPHA_FUTURES_CORE_ALPHA_PILOT_V1`  
Phase: `FUTCORE-P12`  
Summary type: value-free AlphaSpec critique and budget outcome

`FUTCORE-P12` independently critiqued the 40 AlphaSpec drafts from
`FUTCORE-P07` through `FUTCORE-P11`. The records are under
`research/futures_core_alpha_pilot_v1/critiques/`, with the consolidated budget
audit at `research/futures_core_alpha_pilot_v1/alpha_specs/BUDGET_AUDIT.md`.

## Outcome

| Family | Drafts | Accept-for-StudySpec | Revise | Reject |
| --- | ---: | ---: | ---: | ---: |
| Cross-market / relative value | 16 | 4 | 9 | 3 |
| VWAP / session auction | 8 | 2 | 4 | 2 |
| Regime momentum/reversion | 6 | 1 | 4 | 1 |
| Liquidity sweep / objective PA | 6 | 2 | 4 | 0 |
| BBO tradability / confirmation | 4 | 1 | 3 | 0 |
| **Total** | **40** | **10** | **24** | **6** |

The accepted set uses the 10-spec approval cap. The family allocation is
4/2/1/2/1 for cross-market, VWAP/session, regime, liquidity/PA, and BBO. That is
an explicit integer allocation under the 40/20/15/15/10 budget; the tied 15%
families cannot both receive exactly 1.5 accepted specs under a 10-spec cap.

## Budget Verdict

| Cap | Verdict |
| --- | --- |
| 40 draft cap | PASS |
| 10 approved AlphaSpec cap | PASS |
| Family budget | PASS with documented integer rounding for the tied 15% families |
| New FeatureRequest/LabelSpec cap | PASS, none created in P12 |
| Diagnostics survivor cap | PASS, no diagnostics run |
| Watch/candidate cap | PASS, no promotion state created |
| Volume/activity budget | PASS, overlay-only with no standalone family |

## Routing Notes

Every accepted record remains subject to downstream P13/P15 input and label
binding checks, P14 StudySpec construction, and No-Lookahead Auditor review.
Duplicate-exposure hints are preserved for cross-market lead/lag, residual,
rotation, confirmation/divergence, VWAP/session events, regime gates,
liquidity/PA triggers, and BBO overlays.

This phase records specification critique only. It does not claim alpha edge,
profitability, tradability, paper/live readiness, production readiness, broker
readiness, or capital suitability.
